Professional Documents
Culture Documents
View Journal
ChemComm
Accepted Manuscript
This article can be cited before page numbers have been issued, to do this please use: R. mehto, N.
Kumar, V. Bhalla and M. Kumar, Chem. Commun., 2015, DOI: 10.1039/C5CC07098H.
www.rsc.org/chemcomm
Page 1 of 15 Please do not adjust margins
ChemComm
ARTICLE
Roopa was born in India in 1984. She Naresh Kumar belongs to Shahtalai, a
received her bachelor’s and master’s small town in Himachal Pradesh, India.
degree (Hons. School) from the He completed his BSc from H.P.
Department of Chemistry at Guru University, Shimla, and moved to Guru
Nanak Dev University, Amritsar, Nanak Dev University, Amritsar, India
India in 2007. She joined the for MSc-Chemistry in 2007. He joined
research group of Dr. Vandana the research group of Prof. Manoj
Bhalla and completed her doctoral Kumar in the same University, as a
degree in 2012 from Guru Nanak Dev PhD fellow in 2010. Presently, he is
University, Amritsar, India. Her main working with Dr. Isabelle Leray as a postdoctoral fellow at
research focus on the design, synthesis of fluorescent receptors PPSM, ENS-Cachan, France. His research includes the
for species of environmental and biological importance. macrocyclic hosts systems, fluorescent energy transfer systems
for ions/molecules and their applications to bio-imaging.
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1
event. Usually, active sites that are able to interact with target Pyridinium cation
TPP
are integrated with signalling units i.e. fluorophores to develop
fluorescent probes. Further, fluorescent probes provide easily
measurable photophysical changes particularly change in
B Fluorophore
Published on 24 September 2015. Downloaded by Central Michigan University on 24/09/2015 16:12:00.
emission intensity and emission shifts while interacting with the + as DLC unit
Reaction site
analytes. Such types of changes have been attributed to the or
Binding site
working of various photophysical mechanisms such as photo-
induced electron transfer (PET), fluorescence resonance energy
transfer (FRET), intramolecular charge transfer (ICT) and
excimer or exciplex formation. 14-16 Aggregation properties 17 as Fluorophores
as DLC unit
well as spirocyclization18 have also been used to develop
fluorescent systems. In addition, photophysical change induced
by chemical reaction between fluorescent probe and analyte is Fig. 1 Design of mitochondrial targeting fluorescent probes.
also a unique tactic for the detection process.19
In this feature article, we primarily discuss fluorescent diffusion of cationic species towards the membrane over the
molecules designed and applied to target mitochondria with anionic species. This feature of mitochondria distinguishes
their particular applications to detect various species. The them from other organelles and provides opportunity to develop
fluorescent probes have been categorized according to their fluorescent probes that can selectively target the mitochondria.
sensing characteristics into different sections dealing with Among the various cations, especially, the lipophilic cations
reactive oxygen species (ROS), metal ions, gasotransmitters, with delocalised positive charge (DLCs) effectively penetrate
thiols and some miscellaneous examples (two-photon, the hydrophobic barriers of phospholipid layer and
mitochondrial matrix viscosity, pH etc.). The foremost purpose mitochondrial matrix.21 The widely used fluorescent method
of this article is to outline the design approach and involves the covalent linking of mitochondrial targeting group
advancement of fluorescent probes targeting mitochondria i.e. delocalized lipophilic cationic unit and binding site/reaction
along with their applications. site to the fluorophore unit (Fig. 1A). The delocalized lipophilic
cationic unit is connected to fluorophore unit via a flexible
linker to separate it well from the fluorophore. Similarly, the
2. Mitochondrial targeting probes: Designs and binding/reaction site and lipophilic cation unit are separated as
tactics far apart to diminish interaction between them. The commonly
used DLCs to target mitochondria are triphenylphosphonium
The cellular respiration process offers a strong negative (TPP) and pyridinium salts (Fig. 1A). 22-24 These groups possess
membrane potential (-180 mV) in the form of a proton gradient an overall positive charge which facilitates the permeation
across the inner membrane of mitochondria.20 The negative through plasma membrane into mitochondria of cell. Out of
membrane potential of cellular mitochondria facilitates the these lipophilic cations, TPP is explored widely as a
Alteration
Overall Cellular Redox Potential
Cell Death
Diseases and
disorders
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
Fig. 8 Fluorescence changes in 13 with ONOO- and GSH. Fig. 9 Structures of compounds 14-16.
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
(host:guest) stoichiometry and the dissociation constant of the to 100-folds fluorescence enhancement owing to the Cu +
20-Zn2+ complex in a TP mode was found to be 17 ± 2 nM. The mediated cleavage of C-O bond of benzyl ether, resulting in the
TPM and colocalized images of the HeLa cells showed that formation of fluorescent ring-opened species. Further, the
probe preferably target mitochondria. stained subcellular localization and imaging experiments
Lippard et al. developed a reaction based fluorescent probe elucidated that 24 is certainly localized to mitochondria and is
21 for monitoring mitochondrial mobile Zn 2+ ions within the suitable to monitor mitochondrial Cu + in copper supplemented
cells (Fig. 12).69 Initially, probe 21 did not exhibit any cells. Chang et al. reported a bifunctional reporter 25 that
fluorescence emission due to the presence of acetyl group on combines a Cu+ sensitive fluorescent platform with a
phenolic oxygen atoms of xanthene ring which results in mitochondrial-targeting TPP moiety for imaging exchangeable
formation of lactone ring. The addition of Zn 2+ ions caused mitochondrial copper pools in living cells.73 Probe 25 exhibited
hydrolysis of the ester groups which ultimately opens the a poor fluorescence emission at 569 nm (Φ = 0.009) in aqueous
lactam ring of xanthene moiety and gave 140-folds media buffered to physiological pH. The addition of Cu+ ions to
fluorescence enhancement at 529 nm. In addition, probe 21 the solution of probe gave 10-folds (Φ = 0.05) fluorescent
showed partial reversibility with EDTA due to PET from the enhancement along with 11 nm blue shift. The binding analysis
dipicolylamine to xanthene moiety. Probe 21 was found to be using the method of continuous variations (Job’s plot) indicates
localizing in the mitochondria of living cells and monitor 1:1 stoichiometry with stability constant of 7.2 × 10 -12 M.
mobile intracellular zinc ions. The same group also reported Confocal microscopy experiments showed that 25 can detect
resorufin based probes 22 and 23 for detecting mobile zinc ions changes in labile mitochondrial Cu + concentration. Likewise,
in solution as well as in living cells.70 Compounds 22 and 23 25 in conjunction with biochemical and ICP metal analyses
exhibited weak fluorescence emission at 630 nm and 611 nm, revealed that the alterations in mitochondrial metallochaperones
respectively in aqueous buffer solution. The addition of excess did not change exchangeable mitochondrial Cu + or total
of Zn2+ gave 14 and 41-folds fluorescence enhancements, mitochondrial Cu pools relative to control cells.
respectively. Probe 23 showed binding affinity of nanomolar The examples discussed above evidently specify that the
range for zinc ions and non-linear plot demonstrated mitochondrial targeting fluorescent probe is a powerful tool for
dissociation constant of 3.25 ± 0.12 nM. Biological studies real time visualization of metal homeostasis at the cellular
revealed that 22 and 23 are cell permeable and can be used for level. Although a good number of fluorescent probes have been
intracellular zinc imaging. developed for in vivo imaging but there is still lacking of
Copper is another essential metal ion present within certain factors such as long wavelength emission, brightness,
mitochondria matrix and inner-membrane space as a cofactor of fluorophore stability and probe pharmacokinetics.
cytochrome c oxidase (CcO) and superoxide dismutase (SOD1)
5. Probes for mitochondrial gasotransmitters
Gasotransmitters, as the name indicates are small gaseous
molecules that execute distinctive signal functioning in the
cellular system. For example, nitric oxide (NO), the active
member of reactive nitrogen species is generated endogenously
in cells during the conversion of L-arginine to L-citrulline by
nitric oxide synthases (NOS).74,75 NO acts as an intra- and
extracellular messenger, involved in a wide range of biological
processes such as cardiovascular, immune, and the central and
peripheral nervous systems.76,77 The lower level of NO
encourages protective effect on cells, while its higher level
promotes the production of other reactive species such as
ONOO‾, N2O3, NO2‾, and NO3‾ responsible for various
pathophysiological diseases.78,79
Fig. 13 Structures of compounds 22-25.
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7
functions of the mitochondria such as oxygen supply to the endogenous NO in dual-channel mode assisted by intracellular
mitochondria by regulating the oxygen binding or release from GSH and Cys. The similar strategy has been recently employed
haemoglobin and inhibiting the enzyme actions to control the by Chao et al. to develop a two photon Ir(III) phosphorescent
functions of the mitochondria. 80 The utilization of fluorescent probe for the selective monitoring of mitochondrial NO. 86
probes for visualizing NO activity and signalling mechanisms The endogenously produced hydrogen sulfide (H 2S) is
in the mitochondria of living cells showed its importance in the another important gaseous signaling molecule in cellular
biological systems. Xiao et al. reported a fluorescent probe 26 system, generated from cysteine and its derivatives.87 H2S
for the detection of NO in solution and in the mitochondria of regulates a variety of physiological processes such as cell
living cells (Fig. 14).81 The authors utilized rhodamine growth, vasodilation, antioxidation and anti-apoptosis effects.88
spirolactam as a NO signaling moiety and TPP as However, variation in level of H2S is the origin of various
mitochondrial directing unit. Probe 26 upon reaction with NO diseases like Alzheimer’s disease, Down’s syndrome and liver
exhibited 60-folds fluorescence enhancement at 585 nm, cirrhosis.89 H2S is usually produced in the cytosol by the action
attributed to NO-induced spirolactam ring-opening reaction of cystathionine γ-lyase (CSE).90 However, the stress conditions
rhodamine moiety. Probe 26 showed selectivity towards NO facilitate the translocation of cytosol CSE to the mitochondria
over other reactive oxygen/nitrogen species and the detection for the production of H2S. This H2S production regulates the
limit was found to be 4.0 nM. Intracellular studies showed that mitochondrial energy metabolism i.e. the synthesis of ATP by
26 possesses less toxicity at low concentration, pH insensitivity monitoring the level of oxygen. 90 Indeed, H2S performs
and high colocalization coefficient with commercially available essential functions, and its high concentration inhibits the
MitoTracker indicating that this probe localized specifically in activity of the cytochrome c oxidase in mitochondria and is thus
mitochondria. Further real time imaging experiments indicated accountable for the decreased ATP synthesis. Therefore, to
that 26 can effectively detect endogenous and exogenous NO in understand the distribution and activity of H 2S in biological
mitochondria of living cells. systems, the development of technique to measure H 2S is
Nitric oxide mediated cyclization of o-phenylenediamino essential. In this context, He et al. reported mitochondria
moiety to form fluorescent benzotriazole derivative via targeting ratiometric fluorescent probe 28 based on coumarin-
blocking of photo-induced electron transfer process has been an merocyanine scaffolds for cellular H2S (Fig. 16).91 Probe 28 in
appropriate approach for imaging of NO in living cell (Fig. PBS buffer is characterized by the two emission bands at 510
15a).82-84 However, the proton present on benzotriazole moiety and 652 nm due to coumarin and merocyanine
may interfere with the NO detection sensitivity at physiological
pH as its deprotonation can cause the fluorescence quenching
via PET process. Keeping this in mind, Guo et al. developed
mitochondria targetable fluorescent probe 27 in which pyronin
dye is directly linked with one of the amino groups of o-
phenylenediamino moiety for selective and sensitive detection
a
Fluorophore
Non-fluorescent Fluorescent
Fluorophore
8 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 9
10 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
The increased level of superoxide ions in mitochondrion causes of HSO3‾ resulted in the quenching of emission at 590 nm with
lipid peroxidation of its inner membrane which in turn damages the appearance of a new blue shifted emission band at 490 nm.
proteins and mitochondrial DNA via disrupting oxidative
Published on 24 September 2015. Downloaded by Central Michigan University on 24/09/2015 16:12:00.
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 11
12 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 13
61 S. L. Kelleher, N. H. McCormick, V. Velasquez and V. Lopez, 97 K. Shioji, H. Nakamura, H. Masutani and J. Yodoi, Antiox.
Adv. Nutr., 2011, 2, 101. Redox Signal., 2003, 5, 795.
62 S. L. Sensi, H. Z. Yin and J. H. Weiss, Eur. J. Neurosci. 2000, 12, 98 I. Csiki, K. Yanagisawa, N. Haruki, S. Nadaf, J. D. Morrow, D.
3813. H. Johnson and D. P. Carbone, Cancer Res., 2006, 66, 143.
63 S. L. Sensi, P. Paoletti, A. I. Bush, I. Sekler, Nat. Rev. 99 Y. Matsuo and J. Yodoi, Cytokine Growth Factor Rev., 2013,
Neurosci., 2009, 10, 780. 24, 345.
64 K. Sreenath, J. R. Allen, M. W. Davidson and L. Zhu, Chem. 100 C. S. Lim, G. Masanta, H. J. Kim, J. H. Han, H. M. Kim and
Commun., 2011, 47, 11730. B. R. Cho, J. Am. Chem. Soc., 2011, 133, 11132.
65 L. Xue, G. Li, C. Yu and H. Jiang, Chem. Eur. J., 2012, 18, 1050. 101 S.-Y. Lim, K.-H. Hong, D. I. Kim, H. Kwon and H.-J. Kim, J.
66 G. Masanta, C. S. Lim, H. J. Kim, J. H. Han, H. M. Kim and B. R. Am. Chem. Soc., 2014, 136, 7018.
Cho, J. Am. Chem. Soc., 2011, 133, 5698. 102 M. H. Lee, J. H. Han, J.-H. Lee, H. G. Choi, C. Kang and J. S.
67 N. Y. Baek, C. H. Heo, C. S. Lim, G. Masanta, B. R. Cho and H. Kim, J. Am. Chem. Soc., 2012, 134, 17314.
M. Kim, Chem. Commun., 2012, 48, 4546. 103 A. Ishaque and M. J. Al-Rubeai, Immunol. Methods, 1998,
68 K. Rathore, C. S. Lim, Y. Lee and B. R. Cho, Org. Biomol. 221, 43.
Chem., 2014, 12, 3406. 104 A. Varadi and G. A. Rutter, Endocrinology, 2004, 145,
69 W. Chyan, D. Y. Zhang, S. J. Lippard and R. J. Radford, Proc. 4540.
Natl. Acad. Sci. U. S. A., 2014, 111, 143. 105 E. Liang, P. Liu and S. Dinh, Int. J. Pharm., 2007, 338, 104.
70 A. Loas, R. J. Radford and S. J. Lippard, Inorg. Chem., 2014, 106 K. R. Hoyt and I. J. Reynolds, J. Neurochem., 1998, 71,
53, 6491. 1051.
71 C. M. Troy, L. Stefanis, A. Prochiantz, L. A. Greene and M. L. 107 L. F. Yousif, K. M. Stewart and S. O. Kelley, Chem Bio
Shelanski, Proc. Natl. Acad. Sci. U. S. A., 1996, 93, 5635. Chem, 2009, 10, 1939.
72 M. Taki, K. Akaoka, K. Mitsui and Y. Yamamoto, Org. Biomol. 108 H. I. Gursahani and S. Schaefer, Am. J. Physiol.: Heart
Chem., 2014, 12, 4999. Circ. Physiol., 2004, 287, H2659.
73 S. C. Dodani, S. C. Leary, P. A. Cobine, D. R. Winge and C. J. 109 C. Balut, M. vande Ven, S. Despa, I. Lambrichts, M.
Chang, J. Am. Chem. Soc., 2011, 133, 8606. Ameloot, P. Steels and I. Smets, Kidney Int., 2008, 73, 226.
74 W. K. Alderton, C. E. Cooper and R. G. Knowles, Biochem. J., 110 E. Chacon, J. M. Reece, A.-L. Nieminen, G. Zahrebelski, B.
2001, 357, 593. Herman and J. J. Lemasters, Biophys. J., 1994, 66, 942.
75 A. Soneja, M. Drews and T. Malinski, Pharmacol. Rep., 2005, 111 M. F. C. Abad, G. Di Benedetto, P. J. Magalhaes, L. Filippin
57(suppl), 108. and T. Pozzan, J. Biol. Chem., 2004, 279, 11521.
76 S. H. Snyder, Science, 1992, 257, 494. 112 A. M. Porcelli, A. Ghelli, C. Zanna, P. Pinton, R. Rizzuto
77 D. Fukumura, S. Kashiwagi and R. K. Jain, Nat. Rev. Cancer, and M. Rugolo, Biochem. Biophys. Res. Commun., 2005, 326,
2006, 6, 521. 799.
78 F. Pricci, G. Leto, L. Amadio, C. Iacobini, S. Cordone, S. 113 M. Tantama, Y. P. Hung and G. Yellen, J. Am. Chem. Soc.,
Catalano, A. Zicari, M. Sorcini, U. R. Di Mario and G. Pugliese, 2011, 133, 10034.
Free Radical Biol. Med., 2003, 35, 683. 114 M. H. Lee, N. Park, C. Yi, J. H. Han, J. H. Hong, K. P. Kim, D.
79 N. Kumar, V. Bhalla and M. Kumar, Coord. Chem. Rev., 2013, H. Kang, J. L. Sessler, C. Kang and J. S. Kim, J. Am. Chem. Soc.,
257, 2335. 2014, 136, 14136.
80 E. Nisoli and M. O. Carruba J. Cell Sci., 2006, 119, 2855. 115 P. Li, H. Xiao, Y. Cheng, W. Zhang, F. Huang, W. Zhang, H.
81 H. Yu, X. Zhang, Y. Xiao, W. Zou, L. Wang and L. Jin, Anal. Wang and B. Tang, Chem. Commun., 2014, 50, 7184.
Chem., 2013, 85, 7076. 116 M. J. Stutts, C. M. Canessa, J. C. Olsen, M. Hamrick, J. A.
82 E. Sasaki, H. Kijima, H. Nishimatsu, Y. Urano, K. Kikuchi, Y. Cohn, B. C. Rossier and R. C. Boucher, Science, 1995, 269,
Hirata and T. Nagano, J. Am. Chem. Soc., 2005, 127, 3684. 847.
83 T. Terai, Y. Urano, S. Izumi, H. Hojima and T. Nagano, Chem. 117 O. G. Luneva, N. A. Brazhe, N. V. Maksimova, O. V.
Commun., 2012, 48, 2840. Rodnenkov, E. Y. Parsina, N. Y. Bryzgalova, G. V. Maksimov,
84 C. Yu, Y. Wu, F. Zeng, S. Wu, J. Mater. Chem. B, 2013, 1, A. B. Rubin, S. N. Orlov and E. I. Chazov, Pathophysiology,
4152. 2007, 14, 41.
85 Y.-Q. Sun, J. Liu, H. Zhang, Y. Huo, X. Lv, Y. Shi and W. Guo, J. 118 J. S. Goodwin, K. R. Drake, C. L. Remment and A. K.
Am. Chem. Soc., 2014, 136, 12520. Kenworthy, Biophys. J., 2005, 89, 1398.
86 X. Chen, L. Sun, Y. Chen, X. Cheng, W. Wu, L. Ji and H. Chao, 119 A. Kearney-Schwartz, J. M. Virion, J.-F. Stoltz, P. Drouin
Biomaterials, 2015, 58, 72. and F. Zannad, Fund. Clin. Pharmacol. 2007, 21, 387.
87 J. E. Dominy and M. H. Stipanuk, Nutr. Rev., 2004, 62, 348. 120 S. J. Singer and G. L. Nicolson, Science, 1972, 175, 720.
88 M. M. Gadalla and S. H. Snyder, J. Neurochem., 2010, 113, 121 Z. Yang, Y. He, J.-H. Lee, N. Park, M. Suh, W.-S. Chae, J.
14. Cao, X. Peng, H. Jung, C. Kang and J. S. Kim, J. Am. Chem.
89 P. Kamoun, Med. Hypotheses, 2001, 57, 389. Soc., 2013, 135, 9181.
14 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 15